Unravelling Hyperhidrosis: Understanding, Diagnosis, and Treatment

Drashti Dave¹, HunedAli Tinwala², Shah Yug², Sumeet Lalwani², Taufik Mulla^3*

1.      Department of Pharmaceutics, Sigma Institute of Pharmacy, Faculty of Pharmacy, Sigma University, Vadodara -390019, Gujarat, India.

2.      Krishna School of Pharmacy & Research, A Constituent School of Drs. Kiran & Pallavi Patel Global University, Varnama 391240, Vadodara, Gujarat, India.

3.      Institute of Pharmaceutical Sciences, Faculty of Pharmacy, Parul University, P.O. Limda, Tal. Waghodia - 391760, Dist. Vadodara, Gujarat (India).

*Correspondence: e-mail:  mullataufik@gmail.com; Tel.: +917874073349

DOI: https://doi.org/10.71431/IJRPAS.2025.4607     

 INTRODUCTION

Defined as excessive sweating beyond what is necessary to regulate body temperature, hyperhidrosis has serious consequences affecting physical quality of life, emotional quality of life, and social quality of life.[1],[2] Hyperhidrosis is underdiagnosed, but occurs in approximately 1–3% of the global population, and is often overlooked due to social stigma and lack of awareness.[3] There are two principle types; Primary hyperhidrosis and secondary hyperhidrosis with. Each type differenciate in origin, and in symptoms.[4] Primary hyperhidrosis usually has a genetic component, and typically presents in childhood or adolescence. It is localized to specific areas of the body, such as the hands,[5] feet, axilla, or face. Localized hyperhidrosis represents increased sympathetic nervous system activity; the reason why the sympathetic stimulation is excessive is unknown.[6] Secondary hyperhidrosis is that which is associated with conditions such as hyperthyroidism, diabetes, and neurological diseases,[7] and causes of secondary hyperhidrosis can include medications that induce side effects associated with hyperhidrosis (e.g. antidepressants or chemotherapy agents). Sweating in secondary hyperhidrosis affects the whole body, compared to the focal areas associated with primary hyperhidrosis. [8] Epidemiology: Hyperhidrosis is more prevalent than generally recognized and has the capacity to impact everyone regardless of ages and backgrounds. [9] Due to under-reporting and the medical nature of assessing hyperhidrosis with adults and children, the exact prevalence can be complicated. However, the literature indicates that primary hyperhidrosis simply affects about 1-3% of the population.[10] One form of secondary hyperhidrosis – is one of the more common forms and is considered to be from another condition which potentially means there is an even higher prevalence in larger communities around the world. Pathophysiology: The pathophysiological condition of hyperhidrosis is thought to be the hyper-excitability of the sympathetic nervous system and the abnormal signaling to the sympathetic ganglia.[11] When sweat glands are hyperactive, the perspiration is carried out by the sweat glands whether the body is exposed to heat or not or any exertion. [12] Several components are presumably contributing factors, genetic predisposition, levels of neurotransmitter (i.e., acetylcholine) and variation of common sensitivity from sweat glands in those that demonstrate hyperhidrosis.[13] Forms of Hyperhidrosis: Hyperhidrosis can present in many forms and may depend on which area presents and sometimes what the exact cause of the hyperhidrosis. Some distinct types of hyperhidrosis are: Palmar Hyperhidrosis: loss of function with respect to hands and grip over tactile control.[14] Plantar Hyperhidrosis: causes discomfort, odor, and a higher risk of fungal infections.[15] Axillary Hyperhidrosis: causes obvious sweat stains or odor on shirts ultimately leading to social anxiety.[16] Facial Hyperhidrosis: presents with both cosmetic and function aspects.[17]

CAUSES AND TRIGGERS

There are many reasons why people sweat excessively which can be divided into two categories: primary hyperhidrosis and secondary hyperhidrosis. Primary hyperhidrosis tends to start during teenage years and affects certain areas of the body, including the palms of the hands, soles of the feet, armpits or the face.[18] While the reason is unclear, primary hyperhidrosis is probably due to overactivity of the sympathetic nervous system and tends to run in families, suggesting a genetic basis. Secondary hyperhidrosis is usually caused by underlying medical conditions or external factors. Secondary hyperhidrosis can be caused endocrine disorders (i.e. hyperthyroidism, diabetes), menopause, infections (i.e. tuberculosis or HIV) and medications (i.e. antidepressants, antipsychotics).[19] It usually occurs with generalized sweating and presents itself later in life.

Genetics has a major influence on hyperhidrosis and genetics plays a major influence on primary hyperhidrosis, with correlations shown in some studies of gene variants that regulate sweat glands or control nerve activity. Hormonal changes during puberty, pregnancy or menopause may also exacerbate symptoms.[20] Rare conditions like a pheochromocytoma may also result in marked sweating due to excess catecholamines. Neurological disorders such as Parkinson’s disease and multiple sclerosis may also affect normal thermoregulatory control. Environmental factors like heat, humidity, stress, and foods or beverages high in stimulants may also contribute to excessive sweating.[21]

Understanding causes of hyperhidrosis is crucial to creating individualized plans to successfully manage this condition.

SYMPTOMS AND QUALITY OF LIFE IMPACT

Hyperhidrosis can be defined as a medical condition that entails the excessive sweating of a person, whether that person sweats in just a few areas (i.e., palms, soles, axilla) or their entire body.[23] The physical manifestation of hyperhidrosis is often characterized by moisture, skin irritation, and susceptibility to various infections, but the broader effect of hyperhidrosis is often in the emotional and social realms.

For example, constant sweating on the hands and feet can impair the ability to perform activities of daily living (i.e., the ability to hold an object, do fine motor tasks), and physical impairment is not confined to the body; it extends to the mind as well.[24] Provided that constancies exist between sweating and mental health, in the emotional and psychological realm many individuals experience some form of anxiety, embarrassment, or loss of self-esteem from visible sweating to unattractive body odor. The emotional weight hyperhidrosis creates can impact social interactions - leading to withdrawal and isolation but can also lead to depression.

Those who have hyperhidrosis may limit the social aspect of their lives - meaning close or public relationships, as these individuals constantly fear the judgment of the public and this can impact a person's friends or support systems.[25] Work is often greatly challenged by hyperhidrosis. Professions that require precision with manual dexterity or frequent interpersonal relationships, such as healthcare or customer service, can feel monumental in effort. Being judged by coworkers or clients about visible/the potential to sweat on an object, leaving odor or a stain, can impact relationships and confidence in performing.[26]

Diagnosis of Hyperhidrosis

A correct diagnosis is at the heart of proper treatment and improving a patient's quality of life. The patient assessment process includes detailed history-taking, a physical examination, diagnostic testing, and ruling out any other medical condition.[29]

The assessment starts with a detailed interview about the onset and duration, frequency, and distribution of sweating. Physicians will also ask about any aggravating or mitigating factors, the areas of the body affected (for example, the palms, soles, or underarms), any associated factors (for example, odor or change in skin), medications, family history, and how these symptoms affect psychosocial functioning and patients' overall well-being.[30]

In the physical exam, the clinician will examine the sites of excessive sweating for signs of bacterial skin infection and/or other skin irritation, as well as the patients' lymph nodes, thyroid function, vital signs, and neurologic assessment. Diagnostic testing will confirm hyperhidrosis and assist in ruling out secondary causes. For example, the starch-iodine test can provide a visual representation of excessive sweating in specific areas of the body, and gravimetry (weighing the sweat) and evaporimetry (measuring evaporated sweat) can detail exactly how much the patient is sweating. Other tests (e.g., blood tests) help evaluate for endocrine malfunctions (e.g., hyperthyroidism) or hormonal abnormalities.[31]

Determining the differences between primary hyperhidrosis and secondary causes of sweating (e.g., anxiety disorders, diabetes, menopause, infections, neurological dysfunctions [e.g., autonomic neuropathy]) is critical for specific therapy.[32] But the diagnosis may be difficult, as most patients will not report their symptoms honestly, believing they are light or common. Moreover, there are numerous diseases with similar symptoms; thus, diagnostics can be challenging. Using standardized questionnaires and measuring scales can be used to assist in obtaining an objective measurement of.

Using a structured diagnostic method enables healthcare professionals to accurately identify hyperhidrosis, as well as differentiate it from other conditions that mimic hyperhidrosis, and initiate treatment approaches for improved patient outcomes.[33]

Treatment Approaches for Hyperhidrosis

Treating hyperhidrosis involves a variety of treatment selections depending on how badly symptoms affect the patient individually and whether or not previous treatments were effective for the patient. It is necessary to have a slow, careful plan in which the priority is on patient centered care in order to lessen symptoms of hyperhidrosis and to improve quality of life. Available treatments include everything from topical options to surgical options and the introduction of new technology has changed the treatment landscape for hyperhidrosis.

Topical Options: For mild to moderate cases, first-line treatment is most often topical antiperspirant products containing aluminum chloride hexahydrate. These agents obstruct the sweat glands in selected target areas (underarms, hands, feet). Other topical options such as glycopyrrolate wipes and tannic acid preparations can be added as treatments too. There is evidence to suggest that they are safe for long-term use but irritation of the skin may occur.[34],[35]

Oral Medications: If topical treatment is less effective, oral medication may be used, Anticholinergics (e.g., glycopyrrolate, oxybutynin) decrease the amount of sweating that occurs by blocking the signals that activate the glands by inhibiting neuroinnervation. Anticholinergics can have side effects like dry mouth, visual disturbances, and urinary retention which limits their use. Other agents such as beta-blockers, tricyclic antidepressants, or serotonin specific reuptake inhibitors (SSRIs) can be prescribed off-label in patients where the excessive sweating is driven by anxiety.[36]

Botulinum Toxin Injections: Botox is one of the most commonly utilized products for localized hyperhidrosis, particularly in the underarms, palms, and soles. The Botox injections will stop the release of acetylcholine at nerve endings, stopping stimulation of the sweat glands. Botox effects last from 4–6 months and sessions will be needed periodically. The side effects are typically mild with discomfort at the injection site and temporary weakness, but in some cases compensatory sweating may occur in the areas that are not treated.[38]

Iontophoresis: This non-invasive application is well indicated for patients with hands and feet sweating. Iontophoresis applies mild electrical currents as a treatment for excessive sweating, either in water alone or in medicated solutions, decreasing sweat gland activity. Each session usually lasted around 20–40 minutes and requires frequent and regular treatments. Side effects are mild and generally restricted to minimal skin irritation.

Surgical Interventions: When a patient has severe palmar/axillary or otherwise intractable sweating, surgical interventions may be considered. Procedures such as Endoscopic Thoracic Sympathectomy (ETS) involve cutting numerous sympathetic nerves that either cause excessive sweating. Although it is used when indicated, ETS may cause compensatory sweating throughout the body, and requires very selective surgery for patients with the right indications for therapy who are carefully evaluated also in relation to the psychology of treatment.

Other options for lower invasiveness include Laser Sweat Ablation (LSA) which uses intensive laser focused energy to ablate sweat glands, concentrated in the areas of the axilla. Removal of sweat glands can be done surgically, but involves more time for recovery and potential surgical complications.[37]

Emerging Treatments : New technologies are increasing treatment options. Microwave thermolysis is a method of targeted electromagnetic energy that disposes of sweat glands and provides a less invasive option to destroy the sweat-gland tissue while maintaining efficiency.

Laser-based therapies (for instance, fractional lasers) aim at and destroy the tissue that produces sweat while sparing surrounding tissue.

Research is progressing with 2nd generation products based on the neurotoxin with the goal of delivering a new compound to discretely target the inhibition of the sweat gland innervation with more precision and fewer adverse side effects in contrast to typical use of Botox.[39]

LIFESTYLE MODIFICATIONS AND COPING STRATEGIES

Hyperhidrosis is not your typical sweating disorder when it exceeds the normal physiological demands. Hyperhidrosis can present itself as localized (palms, soles, axillae), or as diffuse hyperhidrosis, and many patients whose hyperhidrosis is not significant may categorize this condition as minimally undermining their quality of life. In reality, patients with hyperhidrosis often exacerbate their physical comfort (or discomfort), emotional wellness (or burden), and social functioning.

Impact on Quality of Life

Hyperhidrosis, the physical symptoms of which—persistent moisture, maceration of the skin, infections, irritation, etc.—often have substantial psychosocial consequences. Sweating in the hands and feet may cause fine motor impairment and alter a person's grip and ability to handle day-to-day tasks. The physical signs of sweating, and potential body odor can also lead to avoidance of embarrassment, social fears and anxiety, lack of self-worth, and perhaps, depression.[40] A person may avoid social, sexual, or work situations, either through fear of being stigmatized or judged, leading to isolation and emotional perturbation. The effects are particularly significant in work environments—especially jobs that require interpersonal communication or manual dexterity, (e.g., healthcare, customer service, etc.).

DIAGNOSING HYPERHIDROSIS

An accurate diagnosis is critical to implementing helpful interventions. An accurate diagnosis is thorough and follows an algorithm and includes:

Medical History: A clear and complete exploration of the onset of sweating, frequency of sweating, location of sweating (body area), severity of sweating, exacerbating factors, provoking or associated symptoms (e.g., odor, skin breakdown), other medical history and comorbidities, medication history, and psychosocial impact.[41]

Physical Examination: Assessment of the involved sites, assessment of skin integrity, presence of secondary infections, thyroid assessment, lymph node examination/accompanying pathology, neurological assessment.

Diagnostic Testing:

Gravimetry and Evaporimetry: Quantitative amount of sweat volume.

Blood Screening: Potential secondary causes such as hyperthyroidism or hormonal causes.

Differential Diagnosis: It is important to distinguish primary hyperhidrosis (idiopathic, common, bilateral, generally localized) from secondary causes (endocrine disorders ie., hyperthyroidism and pheochromocytoma involved in sweat production), infections, menopause, medications, and neurological disorders (ie., autonomic neuropathies).

Standardized tools and questioners for the purpose of objectively evaluating severity and helping in treatment planning. Compiling assessment is difficult due to underreporting of hyperhidrosis, overlap of symptoms.

TREATMENT MODALITIES

Management of hyperhidrosis vary and should be individualized and staged, starting non-invasive or less invasive to more aggressive management:

1. Topical Treatments

Initial therapy for mild-moderate hyperhidrosis.

Aluminium chloride hexahydrate; blocks sweat gland ducts. Glycopyrrolate wipes, tannic acid solutions as alternatives.

Side Effects: Skin irritation/dermatitis with long term use.[42]

2. Oral Medications

If topical agents are inadequate.

Anticholinergics; Glycopyrrolate and Oxybutynin; inhibit sweat gland production by acetylcholine.

Beta-blockers and SSRIs and tricyclic antidepressants as off label acute therapies to hyperhidroses - especially if anxiety is a contributing factor. Note: for all systemic agents, side effects are typical (dry mouth, blurred vision, urinary retention).

3. Botulinum Toxin Injections

Effective for focal hyperhidrosis (axillae, palms, soles).

Blocks the release of acetylcholine to inhibit stimulation of sweat glands.

Duration: 4-6 months per treatment. Adverse effects: transient muscle weakness, pain at injection site, compensatory sweating.

4. Iontophoresis

A non-invasive treatment for palmar and plantar hyperhidrosis that uses small electrical currents that are applied in low-intensity water immersion.

Requires multiple treatments; side effects are limited.[43]

5. Surgical options

For severe or uncontrollable hyperhidrosis:

Endoscopic Thoracic Sympathectomy (ETS): Disrupts sympathetic nerve supply which can relieve hyperhidrosis but may cause compensatory hyperhidrosis.

Laser Sweat Ablation (LSA): Eliminates sweat glands through laser destruction.

Surgical Excision: Permanent excision of axillary sweat glands; case-by-case surgical risks and time to recover from surgery.

6. New treatments

New technologies enhance treatment options:

Fractional Laser Therapy: Laser therapy to target sweat ducts without damaging tissue.

FDA-next-generation Neurotoxins: Under investigation and discussed to obtain more selectively desirable results in inhibiting the glands with fewer side effects.

LIFESTYLE CHANGES AND COPING STRATEGIES

Lifestyle modifications may play a helpful part in co-managing medical treatment:

Clothing: Loose, breathable/ventilated and moisture-wicking fabrics can help ease any situation.

Skin Care: You need to have a regime; wash daily, apply absorbent powders on areas prone to excessive moisture, and use ointments to prevent frictional irritation.

Stress Management: Activities for producing parasympathetic nervous regulation. Signals can include: yoga, meditation, exercise, etc. can reduce over stimulation of the sympathetic nervous system.

Support Groups: Structured and informal support groups for individuals with these conditions may ease the emotional toll, help develop coping mechanisms and lessen social isolation.

CLINICAL GUIDELINES AND BEST PRACTICES

The International Hyperhidrosis Society (IHS) offers a framework to develop evidence-based guidelines for the diagnosis and management of hyperhidrosis. The recommendations include:

Individualized Treatment Plans: Based on the foundation, individual patient characteristics, area of hyperhidrosis, and response to prior treatments.

Multimodal Therapy: Where monotherapy is insufficient; therapies can be combined.

Multidisciplinary Teamwork: The dermatologist, neurologist, psychiatrist, endocrinologist and surgeon combine their expertise to provide comprehensive care.

Patient Education: Increases adherence to treatment, facilitates shared decision making and supports patient autonomy.

FUTURE DIRECTIONS IN RESEARCH

Research in hyperhidrosis is progressing steadily striving to provide clarity of the multifactorial pathophysiology and better treatment specificity.

1. Pathophysiology

to assess environmental, neurological, and genetic predictors.

the application of neuroimaging to study how the central nervous system controls sweating.

the search for biomarkers provides opportunities to evaluate early diagnostic tools and clinical management for intervention.

2. New Treatments

the capabilities of artificial intelligence in the development of individualised treatment recommendations.

real-time biomarker assessment of sweating and feedback from wearable devices.

targeted medication delivery without systemic side effects.

3. Genetic therapy and precision.

Pharmacogenomics and biomarker screening factors for personalised treatment.

Gene therapy, RNA interference and CRISPR-Cas9 may provide those who are predisposed with long-lasting, maybe curative treatments.[44]

CONCLUSION

Hyperhidrosis is defined by abundantly excessive sweating that exceeds the thermoregulatory signal from the body. Hyperhidrosis has an immediate impact on The common, yet undertreated hyperhidrosis is often misdiagnosed or mistreated as a result of stigma and misconceived notions. However, with a greater awareness of hyperhidrosis, practitioners can make a difference realizing the considerable impact on the quality of life of those with hyperhidrosis with public health, and a biologically grounded, multidisciplinary understanding. An individualized management plan can be organized through modification of activity, topical management, surgical procedures and emerging treatments. With the advancement in treatment we have many tools to tailor care. With continued research our understanding of hyperhidrosis will improve as we gain knowledge about additional mechanisms of hyperhidrosis, new developments in treatment clinical options, and unmet needs of our patients. Public health awareness and destigmatization in dermatology will provide better interaction with hyperhidrosis patients so they can move on to living fulfilling lives. Humanizing and being solution focused in our care for hyperhidrosis patients allows us to use education, and research to manage hyperhidrosis to alleviate burden, restore dignity and improve the quality of life for people living with hyperhidrosis.

REFERENCES       

1.        Parashar K, Adlam T, Potts G. The Impact of Hyperhidrosis on Quality of Life: A Review of the Literature. Am J Clin Dermatol. 2023 Mar;24(2):187-198. Doi: 10.1007/s40257-022-00743-7. Epub 2023 Jan 9.

2.        Shayesteh A, Brulin C, Nylander E. The meaning of living for men sufering from primary hyperhidrosis. Am J Mens Health 2019;13(6):155798831989272

3.        Nawrocki S, Cha J. The etiology, diagnosis, and management of hyperhidrosis: a comprehensive review. J Am Acad Dermatol. 2019;81(3):657–66

4.        Doolittle J, Walker P, Mills T, Thurston J. Hyperhidrosis: an update on prevalence and severity in the United States. Arch Dermatol Res. 2016;308(10):743–9

5.        Kisielnicka A, Szczerkowska-Dobosz A, Purzycka-Bohdan D, Nowicki RJ. Hyperhidrosis: disease aetiology, classification and management in the light of modern treatment modalities. Postepy Dermatol Alergol. 2022 Apr;39(2):251-257. doi: 10.5114/ada.2022.115887. Epub 2022 May 9.

6.        Hashmonai M, Kopelman D, Assalia A. The treatment of primary palmar hyperhidrosis: a review. Surgery Today. 2000 Mar;30:211-8.

7.        Moraites E, Vaughn O, Hill S. Incidence and prevalence of hyperhidrosis. Dermatol Clin 2014; 32: 457-65.

8.        Swartling C. Hyperhidrosis – an unknown widespread ‘silent’ disorder. J Neurol Neuromed 2016; 1: 25-33.

9.        Gordon J, Hill E. Update on pediatric hyperhidrosis. Dermatol Ther 2013; 26: 452-61

10.    Lear W, Kessler E, Solish N, Glaser DA. An epidemiological study of hyperhidrosis. Dermatologic surgery. 2007 Jan;33:S69-75.

11.    Schick CH. Pathophysiology of hyperhidrosis. Thoracic Surgery Clinics. 2016 Nov 1;26(4):389-93.

12.    Fujimoto T. Pathophysiology and treatment of hyperhidrosis. Perspiration Research. 2016;51:86-93.

13.    Lakraj AA, Moghimi N, Jabbari B. Hyperhidrosis: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins. Toxins. 2013 Apr 23;5(4):821-40.

14.    Vorkamp T, Foo FJ, Khan S, Schmitto JD, Wilson P. Hyperhidrosis: evolving concepts and a comprehensive review. the surgeon. 2010 Oct 1;8(5):287-92.

15.    Stefaniak TJ, Dobosz Ł, Kaczor M, Ćwigoń M. Diagnosis and treatment of primary hyperhidrosis. Polish Journal of Surgery. 2013 Sep 1;85(9):527-43.

16.    Hoorens I, Ongenae K. Primary focal hyperhidrosis: current treatment options and a step‐by‐step approach. Journal of the European Academy of Dermatology and Venereology. 2012 Jan;26(1):1-8.

17.    Nawrocki S, Cha J. The etiology, diagnosis, and management of hyperhidrosis: a comprehensive review: therapeutic options. Journal of the American Academy of Dermatology. 2019 Sep 1;81(3):669-80.

18.    Yamashita N, Tamada Y, Kawada M, Mizutani K, Watanabe D, Matsumoto Y. Analysis of family history of palmoplantar hyperhidrosis in Japan. J Dermatol. 2009 Dec. 36(12):628-31.

19.    Lera M, España A, Idoate MÁ. Focal hyperhidrosis secondary to eccrine naevus successfully treated with botulinum toxin type A. Clin Exp Dermatol. 2015 Mar 28.

20.    Schlereth T, Dieterich M, Birklein F. Hyperhidrosis--causes and treatment of enhanced sweating. Dtsch Arztebl Int. 2009 Jan;106(3):32-7. doi: 10.3238/arztebl.2009.0032. Epub 2009 Jan 16. PMID: 19564960; PMCID: PMC2695293.

21.    Smith FC. Hyperhidrosis. Surgery (Oxford). 2013 May 1;31(5):251-5.

22.    Fujimoto T. Pathophysiology and treatment of hyperhidrosis. Perspiration Research. 2016;51:86-93.

23.    Sato K, Kang WH, Saga K, Sato KT: Biology of sweat glands and their disorders. I. Normal sweat gland function. J Am Acad Dermatol 1989; 20: 537–63.

24.    Ogawa T: Thermal influence on palmar sweating and mental influence on generalized sweating in man. Jpn J Physiol 1975; 25: 525–36

25.    Parashar K, Adlam T, Potts G. The impact of hyperhidrosis on quality of life: a review of the literature. American Journal of Clinical Dermatology. 2023 Mar;24(2):187-98.

26.    Hamm H. Impact of hyperhidrosis on quality of life and its assessment. Dermatologic clinics. 2014 Oct 1;32(4):467-76.

27.    Kamudoni P, Mueller B, Halford J, Schouveller A, Stacey B, Salek MS. The impact of hyperhidrosis on patients' daily life and quality of life: a qualitative investigation. Health and quality of life outcomes. 2017 Dec;15:1-0.

28.    Shayesteh A, Janlert U, Nylander E. Hyperhidrosis–Sweating Sites Matter: Quality of Life in Primary Hyperhidrosis according to the Sweating Sites Measured by SF-36. Dermatology. 2018 Apr 17;233(6):441-5.

29.    Benson RA, Palin R, Holt PJ, Loftus IM. Diagnosis and management of hyperhidrosis. Bmj. 2013 Nov 25;347.

30.    Nawrocki S, Cha J. The etiology, diagnosis, and management of hyperhidrosis: a comprehensive review: therapeutic options. Journal of the American Academy of Dermatology. 2019 Sep 1;81(3):669-80.

31.    Haider A, Solish N. Focal hyperhidrosis: diagnosis and management. Cmaj. 2005 Jan 4;172(1):69-75.

32.    Petrova S, Albanova VI, Guzev KS. Hyperhidrosis: problems and solutions. Vestnik dermatologii i venerologii. 2024 Jan 18.

33.    Hexsel D, Camozzato FO. Hyperhidrosis. InDermatology in public health environments: a comprehensive textbook 2023 Apr 1 (pp. 1839-1856). Cham: Springer International Publishing.

34.    Haider A, Solish N: Focal hyperhidrosis: diagnosis and management. CMAJ 2005; 172: 69–75.

35.    Birner P, Heinzl H, Schindl M, Pumprla J, Schnider P: Cardiac autonomic function in patients suffering from primary focal hyperhidrosis. Eur Neurol 2000; 44: 112–6

36.    Schnider P, Binder M, Auff E, Kittler H, Berger T, Wolff K: Doubleblind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms. Br J Dermatol 1997; 136: 548–52.

37.    Tsiogka A, Agiasofitou E, Tsimpidakis A, Kontochristopoulos G, Stratigos A, Gregoriou S. Management of primary plantar hyperhidrosis with botulinum toxin type A: A retrospective case series of 129 patients. Australasian Journal of Dermatology. 2024 Feb;65(1):49-54.

38.    Fujimoto T, Inose Y, Nakamura H, Kikukawa Y. Questionnaire-based epidemiological survey of primary focal hyperhidrosis and survey on current medical management of primary axillary hyperhidrosis in Japan. Archives of Dermatological Research. 2023 Apr;315(3):409-17.

39.    Fenton C, Kang C. Treat hyperhidrosis with topical therapies first, then dermatological or systemic therapies. Drugs & Therapy Perspectives. 2023 Jun;39(6):200-6.

40.    Stolman LP. Treatment of hyperhidrosis. Dermatologic clinics. 1998 Oct 1;16(4):863-9.

41.    Murray CA, Cohen JL, Solish N. Treatment of focal hyperhidrosis. Journal of cutaneous medicine and surgery. 2007 Mar;11(2):67-77.

42.    Doolittle J, Walker P, Mills T, Thurston J. Hyperhidrosis: an update on prevalence and severity in the United States. Archives of dermatological research. 2016 Dec;308(10):743-9.

43.    Wade R, Moloney E, Layton A, Wright K, Rice S, Jones-Diette J, Stansby G, Levell N, Craig D, Woolacott N. Study Protocol (Draft) Interventional management of hyperhidrosis: a systematic review and value of information analysis (HTA 14/211/02).

44.    Raveglia F, Orlandi R, Guttadauro A, Cioffi U, Cardillo G, Cioffi G, Scarci M. How to prevent, reduce, and treat severe post sympathetic chain compensatory hyperhidrosis: 2021 state of the art. Frontiers in Surgery. 2022 Jan 3;8:814916.